Reducing iron storage levels in vivo via phlebotomies has resulted in improved insulin secretion and peripheral tissue insulin sensitivity, consequently leading to better control of blood glucose and T2DM condition improvement (Fernández-Real et al., 2002). The gene discussed is INS; the disease is type 2 diabetes mellitus.